Recombinant Live Attenuated Influenza Virus Expressing Conserved G-Protein Domain in a Chimeric Hemagglutinin Molecule Induces G-Specific Antibodies and Confers Protection against Respiratory Syncytial Virus

Recombinant Live Attenuated Influenza Virus Expressing Conserved G-Protein Domain in a Chimeric Hemagglutinin Molecule Induces G-Specific Antibodies and Confers Protection against Respiratory Syncytial Virus

Respiratory syncytial virus (RSV) is one of the most important pathogens causing significant morbidity and mortality in infants and the elderly. Live attenuated influenza vaccine (LAIV) is a licensed vaccine platform in humans and it is known to induce broader immune responses. RSV G attachment prot...

Full description

Bibliographic Details
Main Authors: Yu-Jin Jung, Yu-Na Lee, Ki-Hye Kim, Youri Lee, Subbiah Jeeva, Bo Ryoung Park, Sang-Moo Kang
Format: Article
Language:English
Published: MDPI AG 2020-12-01
Series:Vaccines
Subjects:
recombinant LAIV. RSV G
chimeric hemagglutinin
Online Access:https://www.mdpi.com/2076-393X/8/4/716

Similar Items

Similar Items